P
Permanence Bio develops therapeutics focused on preventing DNA damage to address the root causes of aging and disease. The company utilizes an artificial intelligence-driven, high-throughput screening platform to discover novel genome-stabilizing agents. This work aims to create treatments for cancer, genetic diseases, and conditions resulting from radiation or chemical exposure.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Permanence Bio develops therapeutics designed to prevent DNA damage, addressing the root cause of cancer and aging-related diseases. The company utilizes a high-throughput screening platform powered by artificial intelligence to discover novel genome-stabilizing therapies. This approach aims to prevent oncogenesis, treat acute illnesses, and mitigate the effects of genetic diseases and environmental hazards.